News

Cancer-cell reprogramming poses new treatment challenge


 

EXPERT ANALYSIS FROM IMPAKT 2013 BREAST CANCER CONFERENCE

Pages

Recommended Reading

Dexamethasone eases end-of-life cancer-related fatigue
MDedge Hematology and Oncology
USPSTF draft recommendations update chemoprevention for breast cancer
MDedge Hematology and Oncology
Weight loss, exercise can impact cancer incidence and recurrence
MDedge Hematology and Oncology
Ki-67 shows proven clinical utility as a predictive biomarker for breast cancer
MDedge Hematology and Oncology
Pulsed-dye laser erased evidence of breast radiation
MDedge Hematology and Oncology
Supreme Court ponders patenting of human genes
MDedge Hematology and Oncology
Study suggests statin use decreases breast cancer mortality
MDedge Hematology and Oncology
Smaller margins too close for comfort in breast cancer
MDedge Hematology and Oncology
Online cancer community colaunched by ex-Google executive
MDedge Hematology and Oncology
Genetic tests gauge breast-cancer recurrence risk
MDedge Hematology and Oncology